CN102430018B - Medicinal composition for treating rheumatic and rheumatoid arthritis - Google Patents
Medicinal composition for treating rheumatic and rheumatoid arthritis Download PDFInfo
- Publication number
- CN102430018B CN102430018B CN201110382506XA CN201110382506A CN102430018B CN 102430018 B CN102430018 B CN 102430018B CN 201110382506X A CN201110382506X A CN 201110382506XA CN 201110382506 A CN201110382506 A CN 201110382506A CN 102430018 B CN102430018 B CN 102430018B
- Authority
- CN
- China
- Prior art keywords
- rheumatoid arthritis
- medicinal composition
- treatment
- pharmaceutical composition
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title claims abstract description 10
- 230000000552 rheumatic effect Effects 0.000 title abstract description 5
- 201000003068 rheumatic fever Diseases 0.000 title abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 8
- 239000002674 ointment Substances 0.000 claims abstract description 7
- 239000007921 spray Substances 0.000 claims abstract description 6
- 239000000865 liniment Substances 0.000 claims abstract description 5
- 229940040145 liniment Drugs 0.000 claims abstract description 4
- 229940098465 tincture Drugs 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 22
- 239000008194 pharmaceutical composition Substances 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 208000002193 Pain Diseases 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- 230000001717 pathogenic effect Effects 0.000 abstract description 7
- 230000008961 swelling Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 238000010792 warming Methods 0.000 abstract description 5
- 241000271897 Viperidae Species 0.000 abstract description 2
- 229910052957 realgar Inorganic materials 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 240000005779 Jasminum multiflorum Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 241000203394 Tupidanthus Species 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 6
- 231100000862 numbness Toxicity 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000007096 poisonous effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- 206010062575 Muscle contracture Diseases 0.000 description 4
- 208000006111 contracture Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 241000271039 Agkistrodon Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000142992 Acoraceae Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010072132 Fracture pain Diseases 0.000 description 1
- 241000271042 Gloydius halys Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000893545 Liquidambar formosana Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000283967 Manidae Species 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000219926 Myrtaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000196124 Polypodiaceae Species 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000983344 Trachelospermum jasminoides Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating rheumatic and rheumatoid arthritis. The composition consists of twig and leaf of common tupidanthus, pangolin, Fructus evodiae, realgar, long-noded pit viper, angelica, Drynaria rhizome, grassleaf sweelflag rhizome, Chinese starjasmine stem, clematis root, epimedium herb, Fructus liquidambaris, rhubarb, centipede, scorpion, clove and entadae stem. The medicinal composition is prepared into clinically acceptable emplastrum, ointment, pressurized spray, liniment or tincture by adding the conventional auxiliary materials according to the conventional process. The medicinal composition has the effects of expelling pathogenic wind and removing moisture, subsiding swelling and relieving pain, promoting blood circulation and removing blood stasis, warming meridians and unblocking collaterals. The medicinal composition has obvious effect and has no toxic or side effect on the treatment of the rheumatic and rheumatoid arthritis.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of rheumatism and rheumatoid arthritis.
Background technology
Rheumatism belongs to arthromyodynia one class, " so-called numbness person, each with reinfection at that time in the wet gas of wind and cold also "; The cause of disease of disadvantage is a lot, but nothing more than exopathogenic factor and endogenous cause of ill.Brilliantly point out in " Plain Questions numbness opinion ": " wet three gas of wind and cold are assorted extremely, close and are numbness ... ".Modern medicine think rheumatismal pathogenic factors except wind, cold, wet, also comprise infection, immunity, metabolism, endocrine, degeneration, heredity, tumor etc.
Rheumatism and rheumatoid arthritis, the traditional Chinese medical science are thought the disease due to wind and wet two kinds of pathogenic factor combination.Disease opinion has headache, heating, slight perspiration, aversion to wind, heavy sensation of the body, dysuria, joint to ache, can not bend and stretch etc.Arthropathy still with swelling and moving obstacle, is outbreak and alleviates the chronic course of disease alternately except pain is arranged.Because patient's blood circulation is obstructed, cause muscle or organize needed nutrition to carry by blood circulation, cause patient's muscle to lack nutrition and accelerated ageing becomes stiff, serious meeting causes patient's muscle and blood vessel atrophy, some patients were and the joint can occur and disable and viscera function exhaustion.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition for the treatment of rheumatism and rheumatoid arthritis.
The present invention is achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Pharmaceutical composition of the present invention adds conventional adjuvant to make the emplastrum of clinical acceptance, ointment, spray, liniment or tincture according to common process.
Pharmaceutical composition of the present invention has the effect of evil-wind expelling and dampness removing, reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian.To treatment rheumatism and rheumatoid arthritis with remarkable effect, have no side effect.
Following experimental example is used for further illustrating the present invention, but is not limited to the present invention.
One, experimental example
1, clinical observation
Treatment group anthology invention emplastrum (according to embodiment 1 method preparation) treatment rheumatism and 100 patients of Rheumatoid Arthritis, male's 50 examples wherein, women's 50 examples.
Matched group selects bones and muscles pain to paste, and is produced treatment rheumatism and 100 patients of Rheumatoid Arthritis, male's 50 examples wherein, women's 50 examples by Henan Province's space health scientific research company limited.
2, medicament selection
Treatment group: emplastrum of the present invention (according to embodiment 1 method preparation), treat three courses for the treatment of (12 days courses for the treatment of), one pasted/2 days.
Matched group: bones and muscles pain pastes, and is produced by Henan Province's space health scientific research company limited, treats three courses for the treatment of (12 days courses for the treatment of), and one pasted/2 days.
3, diagnostic criteria
1. medical history: the invasion and attack history that wind-cold damp pathogen is arranged.
2. symptom: joint or muscular soreness are arranged, numb, pain.Even severe pain, movable difficult: as to meet cold aggravation.
3. sign: the joint of getting involved is because of function limitation due to pain, but alleviates after activity, and majority of cases is the pain pneumonedema only, and the minority case is in periarticular mild swelling (without red heat).
4. x ray examination: except the visible soft tissue swelling of minority case, generally without sclerotin change.
5. lab testing: erythrocyte sedimentation rate is most normal.Minority is slightly fast: antistreptolysin O (ASO), rheumatoid factor, routine blood test etc. all belong to normal.
6. prognosis: deformity is not stayed in the joint of getting involved after catabasis or healing, and joint function recovery is normal.
4, criterion of therapeutical effect
Draft as follows with reference to " in cure the desease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine 1994 implements:
Recovery from illness: tcm clinical practice symptom, sign disappear or basic the disappearance;
Produce effects: tcm clinical practice symptom, sign obviously change;
Effectively: tcm clinical practice symptom, sign all take a favorable turn;
Invalid: tcm clinical practice symptom, sign are all without obviously improving;
5, therapeutic outcome
The Comparison of therapeutic of table 1 treatment rheumatism and rheumatoid arthritis
| Group | The treatment number | Cure | Produce effects | Effectively | Invalid | Total effective rate |
| Treatment group | 100 | 40 | 29 | 28 | 3 | 97％ |
| Matched group | 100 | 31 | 22 | 30 | 17 | 83％ |
6, conclusion
Treatment group and matched group are treated respectively three courses for the treatment of (12 days each courses for the treatment of), the treatment group invention emplastrum (according to embodiment 1 method preparation) that loses money in a business, and matched group pastes bones and muscles pain and pastes, and is produced by Henan Province's space health scientific research company limited.Therapeutic outcome shows, treatment group total effective rate 97% of the present invention, matched group total effective rate 83%.Treatment group of the present invention obviously is better than matched group.
7, discuss
In pharmaceutical composition of the present invention, the Ramulus et Folium Tupidanthi celyptrati source is leaf, the stem of dicotyledon medicine Araliaceae Ramulus et Folium Tupidanthi celyptrati; Meridian distribution of property and flavor: hardship, temperature; Enter lung, kidney,liver,spleen four warps; Effect: relaxing muscles and tendons and activating QI and blood in the collateral, the circulation of qi promoting damp eliminating, cold expelling dispels the wind, eliminating dampness to stop diarrhea.Cure mainly: be used for traumatic injury, fracture pain person, the arthralgia aggravated by cold of cold and damp stagnation, affection of exogenous wind-cold, heating fear of cold, head-body-pain; Be used for distension and fullness in the abdomen, malaise, anorexia, poor appetite, dysentery person.Squama Manis medical material Ji Yuan: be the scale of Manidae animal Manitis; Salty in the mouth; Cold nature; Return liver, the stomach warp.The Fructus Evodiae source is the almost ripe fruit of rutaceae Fructus Evodiae; Nature and flavor: hot in nature, acrid in the mouth, hardship; Slightly poisonous.Return liver, spleen, stomach, kidney channel; Function cures mainly: dispersing cold for relieving pain, stopping nausea and vomiting by lowering the adverse flow of QI, supporing yang antidiarrheal; Be used for headache, colic, beriberi, dysmenorrhea, abdominal distention, vomiting acid regurgitation, aphtha.Realgar is hot, temperature; Poisonous; Return liver, large intestine channel; Function cures mainly: detoxifcation parasite killing, removing dampness and eliminating phlegm, preventing the attack (or recurrence) of malaria.Agkistrodon: be sharp all dry of Pallas pit viper (Agkistrodon) of kissing of Agkistrodon halys section animal; Sweet, salty, temperature; Poisonous; Return Liver Channel; Function cures mainly: dispels the wind, and collateral dredging, relieving convulsion; Be used for rheumatoid arthritis stubborn, numbness contracture, middle air port is askew, hemiplegia, tic spasm, tetanus, leprosy scabies, malignant boil.Radix Angelicae Sinensis, warm in nature, sweet in the mouth, suffering; Return liver, the heart, spleen channel; Function cures mainly: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Rhizoma Drynariae is the dry rhizome of Plants of Polypodiaceae Mongolian oak Herba pteridii latiusculi; Hardship, temperature; Return kidney, Liver Channel; Function cures mainly: the kidney invigorating bone strengthening continues and hinders pain relieving; Be used for lumbago due to renal deficiency, Hiccough and deaf, odontoseisis, falling winks frustrates, the muscle fracture wound; The external treatment alopecia areata, Rhizoma Acori Graminei belongs to Acoraceae; Suffering, temperature; GUIXIN, the stomach warp; Function cures mainly: removing dampness appetizing, the eliminating phlegm of having one's ideas straightened out, refreshment Fructus Alpiniae Oxyphyllae; Be used for the gastral cavity painful abdominal mass not hungry, mouthful dysentery of keeping silent, coma epilepsy, forgetful deafness.Caulis Trachelospermi is the leaf bine stem of apocynaceae plant trachelospermum jasminoide; Hardship is slightly cold; GUIXIN, liver, kidney channel; Function cures mainly: dispelling wind and removing obstruction in the collateral, removing heat from blood detumescence; Be used for the rheumatism pyretic arthralgia, the contracture of muscle arteries and veins, soreness of waist and knee joint, sore throat, carbuncle, injury from falling down.The Radix Clematidis suffering is salty, and temperature is poisonous; Enter lung, kidney two warps; Has expelling wind and removing dampness, dredge the meridian passage, diuresis, pain relieving effect; Cure mainly rheumatic ostalgia, jaundice, edema, dysuria, migraine, internal traumatic injury.Herba Epimedii is hot, sweet, temperature; Return liver, kidney channel; Function cures mainly: kidney-replenishing, bone and muscle strengthening, wind-damp dispelling; Be used for impotence and seminal emission, the muscles and bones flaccidity is soft, rheumatic arthralgia, numbness contracture; Climacteric hypertension.Fructus Liquidambaris is the dry mature fruit of Hamamelidaceae Plants Chinese sweet gum; Hardship, flat; Return liver, kidney channel; Function cures mainly: dispelling, collateral-activating, and diuretic stimulates the menstrual flow; Be used for arthralgia, numbness contracture, edema distension, the few amenorrhea of breast.Radix Et Rhizoma Rhei is being collectively referred to as of perennial plant of multiple Polygonaceae Rheum, and hardship is cold; Return the stomach warp, large intestine channel, Liver Channel, spleen channel; Effect: attack stagnant; Clearing away damp-heat; Pathogenic fire purging; Removing heat from blood; Blood stasis dispelling; Detoxifcation.Scolopendra is warm in nature, and acrid in the mouth is poisonous; Return liver, spleen, lung meridian; Function with endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.Scorpio is hot, and is flat; Poisonous; Return Liver Channel; Endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Be used for infantile convulsion, the tic spasm, middle air port is askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, migraine and general headache, skin infection.Flos Caryophylli is Myrtaceae syzygium species plant Flos Caryophylli; Suffering, temperature; Effect: warming middle-JIAO, warming the kidney, sending down the abnormal ascending QI; Cure mainly: control singultus, vomiting, regurgitation, dysentery, trusted subordinate's cold type of pain, mass beside the umbilicus, hernia, ringworm.Caulis Entadae is herb or the spore of lycopsid bar helictite; Hot; Temperature; Bitter; Return liver; Urinary bladder channel; Cure mainly expelling wind and dampness; Relaxing muscles and tendons and activating QI and blood in the collateral; Eliminating stasis to stop pain; Diuresis; The main air pain of dampness syndrome; Numb hand and foot; Traumatic injury; Menoxenia.All medicine merging have the effect of evil-wind expelling and dampness removing, reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling, promoting the flow of QI in the collateral by warming the meridian.To treatment rheumatism and rheumatoid arthritis with remarkable effect, have no side effect.
Experimental example two, model case
Case 1: Wang, female, 53 years old.Symptom: winter in 2008 whole body migration arthralgia occurred without obvious inducement, to local hospital chemical examination RF+, was diagnosed as rheumatoid arthritis, gave Radix Tripterygii Wilfordii and extract oral poor effect, arrived afterwards Beijing hospitalize, and effect is still bad.Winter in 2010, patient's interphalangeal joint pain increases the weight of and swelling occurs, bends and stretches difficulty, the slight degeneration in both hands thumb joint.By three courses for the treatment of (12 days each courses for the treatment of) of the invention emplastrum that loses money in a business (according to embodiment 1 method preparation), arthralgia is clearly better afterwards, and function of joint is obviously improved, and continues to use emplastrum of the present invention substantially to recover normally on inspection three courses for the treatment of.
Case 2: Guo, female, 55 years old.Symptom: double knee joint swelling pain 5 years, chemical examination erythrocyte sedimentation rate, anti-chain O are diagnosed as rheumatic arthritis.Oral administration antiinflammatory, analgesic drug product treatment 2 years, poor effect, dead point penicillin treatment first quarter moon, have little effect again, and oral antirheumatism traditional Chinese medicine decoction treatment is 2 years again, and effect is also undesirable, also once does Traditional Chinese medicine permeation and adds the diathermy treatment, also to no effect.Introducing by others afterwards uses ointment of the present invention (according to embodiment 2 method preparations) to treat a course for the treatment of (12 days each courses for the treatment of), symptom obviously alleviates, continue to use the ointment of the present invention just can be freely movable after two courses for the treatment of, continue to strengthen again and be completely recovered after treating two courses for the treatment of.
Case 3: Yang, the man, 40 years old, the Hefei in Anhui people, symptom: the patient got rheumatoid arthritis in the time of 40 years old, often arthralgia is stiff, once took the treatment of plurality of Chinese and Western medicine ibuprofen anti-inflammatory analgetic, pain relief after clothes, but arthroncus, regular heating, 38 ℃-39 ℃ of body temperature.Both hands foods, in, thumb moderate distortion, two elbow joinies swell and ache, not tensible.Red tongue, greasy fur, health is become thin.Blood picture: leukocyte 8000, erythrocyte 3,800,000, platelet 340,000, erythrocyte sedimentation rate 45RE+.Use spray of the present invention (according to embodiment 3 methods preparations) after two courses for the treatment of, arthralgia alleviates, and subjective symptoms takes a turn for the better.Continue subsequently to use two courses for the treatment of, the swollen joint pain disappears, and dysfunction is significantly improved.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1 emplastrum
Add conventional adjuvant to make emplastrum according to common process said medicine, one pasted/2 days.
Embodiment 2 ointments
Add conventional adjuvant to make ointment according to common process said medicine.
Embodiment 3 sprays
Add conventional adjuvant to make spray according to common process said medicine.
Embodiment 4 liniments
Add conventional adjuvant to make liniment according to common process said medicine.
Embodiment 5 tinctures
Add conventional adjuvant to make tincture according to common process said medicine.
Claims (6)
1. a pharmaceutical composition for the treatment of rheumatism and rheumatoid arthritis, is characterized in that, the crude drug of said composition consists of:
2. pharmaceutical composition as claimed in claim 1, is characterized in that, the crude drug of this pharmaceutical composition consists of:
3. pharmaceutical composition as claimed in claim 1, is characterized in that, the crude drug of this pharmaceutical composition consists of:
4. pharmaceutical composition as claimed in claim 1, is characterized in that, the crude drug of this pharmaceutical composition consists of:
5. pharmaceutical composition as described in one of claim 1-4, is characterized in that this pharmaceutical composition adds conventional adjuvant to make the emplastrum of clinical acceptance, ointment, spray, liniment or tincture according to common process.
6. the application of pharmaceutical composition as described in one of claim 1-4 in the medicine of preparation treatment rheumatism and rheumatoid arthritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110382506XA CN102430018B (en) | 2011-11-28 | 2011-11-28 | Medicinal composition for treating rheumatic and rheumatoid arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110382506XA CN102430018B (en) | 2011-11-28 | 2011-11-28 | Medicinal composition for treating rheumatic and rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102430018A CN102430018A (en) | 2012-05-02 |
| CN102430018B true CN102430018B (en) | 2013-06-05 |
Family
ID=45978603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110382506XA Expired - Fee Related CN102430018B (en) | 2011-11-28 | 2011-11-28 | Medicinal composition for treating rheumatic and rheumatoid arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102430018B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102836243B (en) * | 2012-08-25 | 2013-11-06 | 李新欣 | Traditional Chinese medicine for cure of rheumatoid arthritis |
| CN105031519A (en) * | 2015-07-08 | 2015-11-11 | 济南方宇文化传媒有限公司 | Arthritis-treatment traditional Chinese medicine external application preparation and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1833700A (en) * | 2005-03-17 | 2006-09-20 | 乔德松 | Medicinal compsns. for treating rheumatism and rheumatoid arthritis and its prepn. method |
| CN101129697A (en) * | 2007-08-23 | 2008-02-27 | 于春杰 | Orally taken traditional Chinese medicine composition for treating atrophic arthritis |
| CN101530566A (en) * | 2008-03-10 | 2009-09-16 | 王林祥 | Drug for treating rheumatism and rheumatoid disease |
| CN101569682A (en) * | 2008-04-29 | 2009-11-04 | 北京亚东生物制药有限公司 | Medical composition for treating rheumatoid arthritis and preparation method and quality control method thereof |
| CN101637591A (en) * | 2008-08-01 | 2010-02-03 | 梁振兴 | Medicinal composition with functions of strengthening tendons and bones and reviving joints and preparation method |
| CN101912536A (en) * | 2010-07-29 | 2010-12-15 | 贾永全 | Medicinal composition for treating rheumatism and rheumatoid disease |
-
2011
- 2011-11-28 CN CN201110382506XA patent/CN102430018B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1833700A (en) * | 2005-03-17 | 2006-09-20 | 乔德松 | Medicinal compsns. for treating rheumatism and rheumatoid arthritis and its prepn. method |
| CN101129697A (en) * | 2007-08-23 | 2008-02-27 | 于春杰 | Orally taken traditional Chinese medicine composition for treating atrophic arthritis |
| CN101530566A (en) * | 2008-03-10 | 2009-09-16 | 王林祥 | Drug for treating rheumatism and rheumatoid disease |
| CN101569682A (en) * | 2008-04-29 | 2009-11-04 | 北京亚东生物制药有限公司 | Medical composition for treating rheumatoid arthritis and preparation method and quality control method thereof |
| CN101637591A (en) * | 2008-08-01 | 2010-02-03 | 梁振兴 | Medicinal composition with functions of strengthening tendons and bones and reviving joints and preparation method |
| CN101912536A (en) * | 2010-07-29 | 2010-12-15 | 贾永全 | Medicinal composition for treating rheumatism and rheumatoid disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102430018A (en) | 2012-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102225102B (en) | Medicinal liquor for treating rheumatoid arthritis | |
| CN105477564A (en) | Traditional Chinese medicine composition for treating prosopalgia | |
| CN103536858A (en) | Medicine for treating rheumatoid arthritis | |
| CN104491220A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN102430018B (en) | Medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN106265999A (en) | A kind of treat cervical spondylosis, the pill medicine of lumbar spondylosis and preparation method | |
| CN102441094B (en) | Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN104069355A (en) | Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN103550479A (en) | Externally applied composition for treating rheumatic pain | |
| CN102872252B (en) | Medicinal composition for treating rheumatic pain | |
| CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
| CN110893206B (en) | Externally applied medicine for treating rheumatic arthritis and preparation method thereof | |
| CN114796434A (en) | Pill for keeping healthy qi and pathogenic factors dry | |
| CN106267075A (en) | A kind of Chinese medicinal capsule for treating ankylosing spondylitis | |
| CN104887792A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
| CN105616947A (en) | Heat and dampness removing traditional Chinese medicine for treating acute gouty arthritis | |
| CN105362986A (en) | Traditional Chinese medicine composition for treating rheumatism cold disease | |
| CN104435883A (en) | Traditional Chinese medicine preparation for treating calcaneodynia | |
| CN105194205A (en) | Chinese herbal medicine composition for treating fracture and joint soft tissue injury | |
| CN104474210A (en) | Traditional Chinese medicine composition for treating unstable angina pectoris caused by qi stagnation and blood stasis | |
| CN104887841A (en) | Traditional Chinese medicine preparation for treating gout | |
| CN104524378A (en) | Tendon-relaxing and collateral-activating tincture for treating chronic periarthritis of shoulder | |
| CN104547359A (en) | Traditional Chinese medicine composition for treating spleen deficiency and dampness stagnation type eczema | |
| CN103550620A (en) | External medicinal composition for treating pain from rheumatism | |
| CN102028810A (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130605 |